Subtype
Malignant Colorectal Neoplasm
CI-CAN-00005874Explore in graph →
1,565 active trials21 approved drugs382 evidence items
- NCIt
- C4978
- DOID
- 9256
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00005874Explore in graph →
Clinical trials
7,296 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (722)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01745874 | Diagnostic Value of Whole-Body MRI for Rectal Cancer Preoperative Staging | unknown | — | 20 | University of Lausanne HospitalsOTHER | 1 | Dec 10, 2012 | clinicaltrials |
| NCT00601549 | A Randomized Controlled Clinical Trial Comparing Oncological Results and Functional Recovery Between Laparoscopic and Open Method for the Treatment of Advanced Rectal Cancer After Concurrent Chemoradiation Therapy (CCRT) | unknown | Phase 3 | 600 | National Taiwan University HospitalOTHER | 1 |
| Dec 6, 2012 |
| clinicaltrials |
| NCT01744509 | PillCam Colon Capsule 2® (PCC2) in the Setting of Colorectal Cancer Screening Program | unknown | N/A | 35 | Valduce HospitalOTHER | 1 | Dec 6, 2012 | clinicaltrials |
| NCT01320319 | Effect of EPA on Aerobic Performance, Muscle, and Quality of Life in Colorectal Cancer Surgery Patients(EPA-colo) | unknown | Phase 2 / Phase 3 | 70 | University of NottinghamOTHER | 1 | Dec 4, 2012 | clinicaltrials |
| NCT00387348 | Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer | terminated | Phase 3 | 24 | Massachusetts General HospitalOTHER | 1 | Dec 3, 2012 | clinicaltrials |
| NCT01736904 | wXELIRI Versus FOLFIRI Regimen in the Treatment of Advanced Colorectal Cancer Patients | unknown | Phase 2 | 100 | Fudan UniversityOTHER | 1 | Nov 29, 2012 | clinicaltrials |
| NCT01227239 | Preoperative S-1/OHP With Radiation Therapy for Low-lying Rectal Carcinoma in Neo-adjuvant Setting | unknown | Phase 1 / Phase 2 | 45 | Japan Clinical Cancer Research OrganizationOTHER | 1 | Nov 27, 2012 | clinicaltrials |
| NCT01243047 | Intermittent Versus Continuous Tarceva Study | completed | Phase 2 | 60 | Chinese University of Hong KongOTHER | 1 | Nov 22, 2012 | clinicaltrials |
| NCT01519609 | Trial Comparing Moviprep and Phosphoral as Bowel Prep Before Colonoscopy | completed | N/A | 400 | Randers Regional HospitalOTHER | 1 | Nov 21, 2012 | clinicaltrials |
| NCT01700283 | Developing Objective Fatigue Indicators in Colorectal Cancer Survivors. | unknown | N/A | 306 | National Taiwan University HospitalOTHER | 1 | Nov 14, 2012 | clinicaltrials |
| NCT00128622 | Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer | completed | Phase 1 | 24 | H. Kim LyerlyOTHER | 1 | Nov 12, 2012 | clinicaltrials |
| NCT01483040 | PeerScope B System™ Clinical Protocol | completed | N/A | 50 | PeerMedical Ltd.INDUSTRY | 1 | Nov 8, 2012 | clinicaltrials |
| NCT00375024 | Patient Navigator Project | completed | N/A | 1,267 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Nov 6, 2012 | clinicaltrials |
| NCT00284258 | Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer | completed | Phase 2 / Phase 3 | 426 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 2, 2012 | clinicaltrials |
| NCT00478634 | A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer | completed | Phase 1 | 19 | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 2, 2012 | clinicaltrials |
| NCT00569335 | Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer | completed | Phase 2 | 52 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 2, 2012 | clinicaltrials |
| NCT00569699 | Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC) | completed | Phase 2 | 56 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 2, 2012 | clinicaltrials |
| NCT00569790 | Phase II Trial of Combination Therapy With Irinotecan, S-1, and Bevacizumab (IRIS/Bev) in Patients With Unresectable or Recurrent Colorectal Cancer | completed | Phase 2 | 53 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 2, 2012 | clinicaltrials |
| NCT00721916 | Randomized Phase II Study of SOL for Untreated Metastatic Colorectal Cancer | completed | Phase 2 | 107 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 1, 2012 | clinicaltrials |
| NCT00849394 | Evaluation of Protein in the Urine in Patients Receiving Bevacizumab | completed | — | 106 | North Texas Veterans Healthcare SystemFED | 1 | Nov 1, 2012 | clinicaltrials |
| NCT00030524 | ZD 1839 in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer | completed | Phase 2 | — | The University of Texas Health Science Center at San AntonioOTHER | 1 | Oct 30, 2012 | clinicaltrials |
| NCT00385970 | A Phase III Trial Comparing UFT+PSK to UFT+LV in Stage IIB, III Colorectal Cancer | unknown | Phase 3 | 380 | Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment GroupOTHER | 1 | Oct 26, 2012 | clinicaltrials |
| NCT00278889 | Second Line ColoRectal Cancer Therapy in Combination With Combination of FOL- Folinic Acid(Leucovorin), F - Fluorouracil and OX - Oxaliplatin (FOLFOX)(HORIZON I) | completed | Phase 2 | 215 | AstraZenecaINDUSTRY | 9 | Oct 24, 2012 | clinicaltrials |
| NCT01346917 | Effect of Intravenous Lidocaine on the Tolerability of Early Oral Feeding After Laparoscopic Colorectal Surgery | completed | N/A | 77 | Kangbuk Samsung HospitalOTHER | 1 | Oct 17, 2012 | clinicaltrials |
| NCT01655641 | Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery(TMGS) | unknown | Phase 2 / Phase 3 | 118 | Tribhuvan University Teaching Hospital, Institute Of Medicine.OTHER | 1 | Oct 16, 2012 | clinicaltrials |
| NCT01707511 | The Investigation of the EtCO₂- PaCO₂ Relation During Laparoscopic Colon Surgery | unknown | — | 40 | Diskapi Teaching and Research HospitalOTHER | 1 | Oct 16, 2012 | clinicaltrials |
| NCT01237665 | IXO (Irinotecan, Xeloda, Oxaliplatin) in Rectal Cancer(IXOr) | unknown | Phase 2 | 15 | Ottawa Hospital Research InstituteOTHER | 1 | Oct 15, 2012 | clinicaltrials |
| NCT01189877 | Characterization of Rectal Cancer Hypoxia Using pO2 Histography and Immunohistochemistry for Hypoxia-Related Proteins | completed | N/A | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 11, 2012 | clinicaltrials |
| NCT00436072 | ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal Cancer | completed | Phase 1 | 46 | Dana-Farber Cancer InstituteOTHER | 1 | Oct 4, 2012 | clinicaltrials |
| NCT00597610 | Evaluating The Response to Pre-Operative Chemotherapy and/or Radiation Therapy For Rectal Cancer Using Three-Dimension Transrectal Ultrasound | completed | N/A | 84 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 27, 2012 | clinicaltrials |
| NCT00005640 | Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Treatment of Colorectal Cancer | completed | N/A | 17 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 25, 2012 | clinicaltrials |
| NCT00004885 | Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 3 | 430 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Sep 24, 2012 | clinicaltrials |
| NCT00043004 | Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer | terminated | Phase 2 | 119 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 10 | Sep 24, 2012 | clinicaltrials |
| NCT00064181 | Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 3 | 86 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Sep 24, 2012 | clinicaltrials |
| NCT00098943 | NGR-TNF in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 70 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 2 | Sep 24, 2012 | clinicaltrials |
| NCT00349336 | A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer. | completed | Phase 3 | 64 | Hoffmann-La RocheINDUSTRY | 3 | Sep 18, 2012 | clinicaltrials |
| NCT00101894 | Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer | completed | Phase 1 | 119 | AmgenINDUSTRY | 0 | Sep 17, 2012 | clinicaltrials |
| NCT00025532 | Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer | withdrawn | Phase 1 | 0 | University of California, San FranciscoOTHER | 1 | Sep 14, 2012 | clinicaltrials |
| NCT00004252 | Leucovorin and Fluorouracil With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 3 | — | PfizerINDUSTRY | 1 | Sep 11, 2012 | clinicaltrials |
| NCT00981110 | Standard Versus Advanced Antimicrobial Dressing Containing Ionic Silver Following Colorectal Cancer Surgery(AM) | completed | Phase 3 | 120 | European Institute of OncologyOTHER | 1 | Sep 11, 2012 | clinicaltrials |
| NCT00544336 | Family Quality of Life Among Families With a Member Who is a Cancer Patient | completed | — | 366 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Sep 10, 2012 | clinicaltrials |
| NCT00136227 | Use and Decision-making About Colorectal Cancer Screening Among Hispanic Men and Women | completed | N/A | 521 | Centers for Disease Control and PreventionFED | 1 | Sep 7, 2012 | clinicaltrials |
| NCT00137592 | Promoting Colorectal Cancer Screening in Rural Colorado | completed | N/A | 480 | Centers for Disease Control and PreventionFED | 1 | Sep 7, 2012 | clinicaltrials |
| NCT01072851 | Tools for Improving Colorectal Cancer Screening Rates: Multimedia Versus Print | completed | Phase 3 | 920 | Trinity Health Of New EnglandOTHER | 1 | Sep 7, 2012 | clinicaltrials |
| NCT01575340 | Study to Assess the Effect of Consumption of Fish Oil Encapsulated on Inflammatory Markers in Colorectal Cancer | completed | N/A | 11 | Universidade Federal de Santa CatarinaOTHER | 1 | Sep 6, 2012 | clinicaltrials |
| NCT01679327 | Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal Cancer | unknown | Phase 2 | 100 | Chinese Academy of Medical SciencesOTHER | 1 | Sep 6, 2012 | clinicaltrials |
| NCT01679756 | INtracorporeal Versus EXTracorpoREal anastoMOsis After Laparoscopic Right Colectomy for Cancer(INEXTREMO) | unknown | N/A | 384 | Ospedale Misericordia e DolceOTHER | 1 | Sep 6, 2012 | clinicaltrials |
| NCT00607282 | Efficacy of Udenafil After Radical Resection for Sigmoid Colon and Rectal Cancer | completed | Phase 2 | 46 | Seoul National University HospitalOTHER | 1 | Sep 5, 2012 | clinicaltrials |
| NCT00118261 | Erlotinib, Modified FOLFOX6, and Bevacizumab as First-Line Therapy Metastatic Colorectal Cancer | completed | Phase 1 | 17 | Case Comprehensive Cancer CenterOTHER | 1 | Sep 3, 2012 | clinicaltrials |
| NCT01251666 | Comparison of Hemoccult, Magstream and OC-Sensor Faecal Occult Blood Tests in Colorectal Cancer Screening(HeMO) | completed | Phase 3 | 19,797 | University Hospital, CaenOTHER | 1 | Sep 3, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Dec 10, 2012source: clinicaltrials